These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22633734)

  • 1. Comment on "Hyperacute rejection from a donor who died of carbamate intoxication-a case report".
    Farzad G
    Am J Emerg Med; 2012 Jul; 30(6):1008-9; author reply 1009-10. PubMed ID: 22633734
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperacute rejection from a donor who died of carbamate intoxication--a case report.
    Chan YH; Liew KP; Sun CC; Hsueh C; Li BC; Tsai FC; Lin JL; Chu PH
    Am J Emerg Med; 2012 Oct; 30(8):1661.e1-4. PubMed ID: 22030195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease in autologous stem cell transplantation: critical care for critical condition.
    Kittanamongkolchai W; Srivali N; Ratanapo S; Cheungpasitporn W; Leonardo JM
    Am J Emerg Med; 2013 Apr; 31(4):748-9. PubMed ID: 23399328
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
    J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart transplantation from donors of different ABO blood type.
    Neves C; Prieto D; Sola E; Antunes MJ
    Transplant Proc; 2009 Apr; 41(3):938-40. PubMed ID: 19376393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperacute graft rejection during heart transplantation for giant cell myocarditis: a case report.
    Mutijima E; Delbecque K; Defraigne JO; Bouillenne C; Damas P; Pierard L; Boniver J; de Leval L
    Pathol Res Pract; 2010 Jun; 206(6):411-4. PubMed ID: 20089370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic mechanisms of cardiac transplant rejection.
    Duquesnoy RJ; Cramer DV
    Cardiovasc Clin; 1990; 20(2):87-103. PubMed ID: 2404607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived microchimerism in heart transplant recipients: a parameter for immunological risk?
    Hisanaga M; Schlitt HJ; Hundrieser J; Nakajima Y; Kanehiro H; Nakano H; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1036-8. PubMed ID: 8623219
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors.
    Cooper DK
    J Heart Transplant; 1990; 9(4):376-81. PubMed ID: 2398432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated responses to donor endothelium: concerning the concern.
    Hosenpud JD
    J Heart Lung Transplant; 1997 Jun; 16(6):687. PubMed ID: 9229302
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 13. Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft.
    Kamei T; Yasunami Y; Arima T; Ryu S; Ueki M; Konomi K
    Transplant Proc; 1992 Dec; 24(6):2885-6. PubMed ID: 1281579
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-specific cardiac allograft tolerance without immunosuppression after intrathymic injection of donor alloantigen.
    Goss JA; Nakafusa Y; Flye MW
    Transplant Proc; 1992 Dec; 24(6):2879-80. PubMed ID: 1465981
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxoplasmic cyst and heart transplant: a case report of serological reactivation in an acute graft rejection context].
    Desoubeaux G; Perret-Gallix K; Machet MC; Sirinelli A; Bailly E; Van Langendonck N; Chandenier J
    Ann Biol Clin (Paris); 2012; 70(3):323-8. PubMed ID: 22565180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO-incompatible heart transplantation in infants.
    West LJ; Pollock-Barziv SM; Dipchand AI; Lee KJ; Cardella CJ; Benson LN; Rebeyka IM; Coles JG
    N Engl J Med; 2001 Mar; 344(11):793-800. PubMed ID: 11248154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance to cardiac allografts by pretreatment with intrathymic UVB donor spleen cells.
    Oluwole SF; Chowdhury N; Fawwaz R; Hardy MA
    Transplant Proc; 1992 Dec; 24(6):2904-5. PubMed ID: 1465993
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of donor gender on patient mortality after heart transplantation.
    Bryan CF; Mitchell SI; Borkon AM; Curtis J; Demmy T; Estep TH; Moran J
    Transplant Proc; 1996 Feb; 28(1):149-51. PubMed ID: 8644151
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of accelerated rejection of intravenously transplanted allogeneic lymphocytes by donor-specific transfusion-treated rats.
    Olszewski WL; Jasklowska-Englisz M; Adamczyk G
    Transplant Proc; 1992 Dec; 24(6):3000-1. PubMed ID: 1466033
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
    Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.